Inventor · disambiguated record
Roch Boivin
Also filed as: BOIVIN ROCH
17 granted patents·3 pending applications·129 citations·filing 2003–2021
92Inventor score
Top patents by PatentIndex Score
20 records- 0197US11001561B2Pyrimidinone derivatives as SHP2 antagonistsMERCK PATENT GMBH·Filed 2020·Granted May 11, 2021·26 cites·19 claims
- 0296US11033547B2Carboxamide-pyrimidine derivatives as SHP2 antagonistsMERCK PATENT GMBH·Filed 2020·Granted Jun 15, 2021·26 cites·24 claims
- 0393US9126999B2Tetrahydropyrazolopyrimidine compoundsBOIVIN ROCH·Filed 2013·Granted Sep 8, 2015·33 cites·28 claims
- 0490US9446046B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2015·Granted Sep 20, 2016·8 cites·6 claims
- 0584US8329742B2Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2010·Granted Dec 11, 2012·9 cites·32 claims
- 0683US10640500B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted May 5, 2020·1 cites·5 claims
- 0783US9850242B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2016·Granted Dec 26, 2017·3 cites·12 claims
- 0882US9440968B2Substituted pyrido[3,2-d]pyrimidines for treating cancerMERCK PATENT GMBH·Filed 2013·Granted Sep 13, 2016·5 cites·14 claims
- 0982US7799827B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Sep 21, 2010·16 cites·30 claims
- 1072US8350059B2Intermediates and methods for making zearalenone macrolide analogsEISAI R&D MAN CO LTD·Filed 2008·Granted Jan 8, 2013·1 cites·24 claims
- 1170US11702392B2Pyrimidinone derivatives as SHP2 antagonistsMERCK PATENT GMBH·Filed 2021·Granted Jul 18, 2023·0 cites·6 claims
- 1270US11130758B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2020·Granted Sep 28, 2021·0 cites·9 claims
- 1367US9663486B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted May 30, 2017·1 cites·14 claims
- 1465US11696916B2Carboxamide-pyrimidine derivatives as SHP2 antagonistsMERCK PATENT GMBH·Filed 2021·Granted Jul 11, 2023·0 cites·6 claims
- 1565US11542246B2Quinoline compounds as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Jan 3, 2023·0 cites·3 claims
- 1657US10233160B2Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitorsMERCK PATENT GMBH·Filed 2018·Granted Mar 19, 2019·0 cites·12 claims
- 1756US2013211103A1Intermediates and methods for making zearalenone macrolide analogsEISAI R&D MAN CO LTD·Filed 2013·Application pending·0 cites
- 1852US9981925B2Substituted benzo[d][1,2,3]triazines as p70S6K inhibitorsMERCK PATENT GMBH·Filed 2016·Granted May 29, 2018·0 cites·12 claims
- 1951US2013196987A1Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2012·Application pending·0 cites
- 2048US2009197867A1Enantiomerically enriched imidazoazepinone compoundsSPYVEE MARK·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →